Ketorolac Eg

Ketorolac Trometamol, the active ingredient in Ketorolac Eg, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a sterile injectable solution for intramuscular and intravenous use. It provides analgesia for moderate to severe pain, particularly postoperative pain, in adult patients and is indicated for short‑term management of acute pain in surgical settings.

GNH USA supplies Ketorolac Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable batch release, cold‑chain logistics where required, and regulatory support for cross‑border procurement.

Ketorolac Trometamol is an NSAID that reduces pain by inhibiting cyclooxygenase‑mediated prostaglandin production.

- Postoperative pain: provides short‑term relief of moderate to severe pain after surgical procedures. - Acute musculoskeletal pain: reduces pain and inflammation associated with sprains, strains, and soft‑tissue injuries. - Dental pain: offers rapid analgesia following oral surgery or extractions. - Renal colic: alleviates severe flank pain caused by kidney stones. - Acute migraine (when other therapies fail): can be used for brief, intense headache relief.

Ketorolac Trometamol may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Nausea or vomiting - Headache - Dizziness or vertigo - Injection‑site pain or erythema - Dyspepsia or abdominal discomfort - Diarrhoea

Serious or Rare Side Effects: - Gastrointestinal bleeding or perforation - Acute renal failure or worsening of chronic kidney disease - Severe hypersensitivity reactions, including anaphylaxis - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Cardiovascular thrombotic events such as myocardial infarction or stroke

Ketorolac should be used with caution, taking into account patient‑specific risk factors and clinical context.

- Renal function: assess baseline renal status and avoid use in severe renal impairment. - Bleeding risk: avoid in patients with active peptic ulcer disease, recent hemorrhage, or concurrent anticoagulant therapy. - Cardiovascular disease: use cautiously in patients with coronary artery disease or uncontrolled hypertension. - Pregnancy: contraindicated in the third trimester and should be avoided unless benefits outweigh risks. - Concomitant NSAIDs or aspirin: avoid combined use to reduce gastrointestinal and renal toxicity. - Store below 25°C: keep in the original container, protect from light and moisture.

Ketorolac can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Lithium: ketorolac may raise serum lithium concentrations, risking toxicity. - Methotrexate: reduced clearance may lead to methotrexate toxicity.

Moderate Interactions (Monitor Closely): - Corticosteroids: combined use heightens the chance of gastrointestinal ulceration. - Selective serotonin reuptake inhibitors (SSRIs): may increase bleeding tendency.